Mike Polark
Stock Analyst at Baird
(2.12)
# 2,822
Out of 5,182 analysts
87
Total ratings
40.35%
Success rate
-2.27%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Outperform | $220 → $200 | $125.96 | +58.78% | 14 | Feb 20, 2026 | |
| INSP Inspire Medical Systems | Downgrades: Peer Perform | n/a | $55.07 | - | 11 | Feb 13, 2026 | |
| MDLN Medline | Initiates: Outperform | $47 | $45.23 | +3.91% | 1 | Jan 12, 2026 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $83.46 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $82.92 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $10.65 | +87.79% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $63.41 | -5.38% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $188.31 | +85.86% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $22.23 | +30.45% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $222.02 | -18.93% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $92.59 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $329.01 | +23.10% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $470.99 | +6.80% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $92.80 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $135.07 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $61.41 | +97.04% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $19.82 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $15.81 | +58.13% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $178.66 | -7.65% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $59.95 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $17.25 | -24.64% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $3.00 | +600.00% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $222.19 | +12.52% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $0.88 | +4,786.36% | 1 | Sep 2, 2020 |
iRhythm Holdings
Feb 20, 2026
Maintains: Outperform
Price Target: $220 → $200
Current: $125.96
Upside: +58.78%
Inspire Medical Systems
Feb 13, 2026
Downgrades: Peer Perform
Price Target: n/a
Current: $55.07
Upside: -
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $45.23
Upside: +3.91%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $83.46
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $82.92
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $10.65
Upside: +87.79%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $63.41
Upside: -5.38%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $188.31
Upside: +85.86%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $22.23
Upside: +30.45%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $222.02
Upside: -18.93%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $92.59
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $329.01
Upside: +23.10%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $470.99
Upside: +6.80%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $92.80
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $135.07
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $61.41
Upside: +97.04%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $19.82
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $15.81
Upside: +58.13%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $178.66
Upside: -7.65%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $59.95
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $17.25
Upside: -24.64%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $3.00
Upside: +600.00%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $222.19
Upside: +12.52%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $0.88
Upside: +4,786.36%